Vnus Medical Technologies, Inc.

Fulfillium, Inc.

Covidien LP

Tyco Healthcare Group LP

Shalon Ventures, Inc.

Intervene, Inc.

Airxpanders, Inc.

Tautona Group Research and Development Company, L.l.c.

Pfizer Corporation

Hewlett-packard Development Company, L.p.

Acclarent, Inc.

Lifecell Corporation

Tusker Medical, Inc.

Absolutions Med, Inc.

Acclarnet, Inc.

Christopher Scott Jones

Arthur W Zikorus

Joseph M Tartaglia

Brian Eugene Farley

Mark P Parker

Reinhold H Dauskardt

Craig A Johanson

Michael Stephan Mirizzi

Richard D Y Chen

Daniel Jacobs

Douglas M Petty

Marc B Taub

David S Mintz

Aaron V Kaplan

Tadmor Shalon

Craig A Purdy

Joseph Rimsa

Dawn A Henderson

F Mark Payne

Ryan S Han

Robert Vaughan

Douglas Sutton

Mariel Fabro

Brady David Esch

Fletcher T Wilson

Benjamin Kahn Cline

Bob McRae

Michael H Rosenthal

Michael John Munchhof

Geoffrey C Gurtner

Kenneth N Horne

Brian J Domecus

Lawrence Alan Reiter

Paul James Lingane

Sergio Salinas

Susan D La Greca

Qifang Li

Mark B Taub

Rhunjay James Yu

Gregory Lamps

Brad Richardson

James Gilbert Chandler

R James Yu

Richard Chen

Ralph G DePalma

Michael D Oldham

Leigh Boros

Frederick Mark Payne

Paul J Lingane

Mark F Payne

Robert G Mcrae

Medical systems, devices and methods for creation of autologous tissue valves within a mammalian body are disclosed. One example of a device for creating a valve flap from a vessel wall includes an elongate tubular structure having a proximal portion and a distal portion and a longitudinal axis; a first lumen having a first exit port located on the distal portion of the elongate tubular structure; a second lumen having a second exit port located on the distal portion of the elongate tubular structure; a recessed distal surface on the distal portion of the elongate tubular structure, wherein the recessed distal surface is located distally to the first exit port; and an open trough on the recessed distal surface extending longitudinally from the first exit port.

Systems and methods for endoluminal valve creation

An abdominal closure method and device is disclosed where the device generally includes a first tissue securement member configured for securement to a first tissue region and a second tissue securement member configured for securement to a second tissue region. The first and second tissue securement members are coupled to the connecting member and the connecting member is positionable at a distance from the first and second tissue regions. Additionally, one or more biasing elements may be connected to the first and second tissue securement members to approximate the first and second tissue regions towards one another via respective securement members.

Abdominal closure method and device for ventral hernia

In one aspect, an obesity treatment device includes multiple inflatable space-filling compartments and a valve system for introducing fluid into each compartment, where the device forms, upon filing the compartments, to a curved shape conforming to a natural three-dimensional kidney shape of the stomach. In one aspect, a method for deploying a gastric balloon structure in a gastric cavity includes determining dimensions of the gastric cavity in a feeding state, selecting a fill volume for each of a number of isolated chambers of the balloon structure, and filling each chamber while the balloon structure is in the gastric cavity. In one aspect, a system for treating obesity includes a means for conforming a flexible, space-filling structure to a natural kidney shape of the gastric cavity, a means for maintaining at least two isolated inflatable regions of the flexible, space-filling structure, and a means for introducing fluid into each inflatable region.

Methods, devices, and systems for obesity treatment

Tissue expanders and their methods of use.

Tissue expanders and methods of use

In one aspect, a gastric balloon structure includes multiple isolated non-concentric inflatable chambers and a valve system for introducing fluid into each chamber, where the structure assumes, upon inflating, a curved shape conforming to a natural three-dimensional kidney shape of the gastric cavity.

Devices, systems, methods, and kits for treating the tissue structures of the ear make use of a guide structure that can mechanically register a treatment probe with a target region of a target tissue, the guide structure being fittingly received in an auditory canal and often comprising a conformable body such as a compressible foam, or the like. The guide structure may include an articulating mechanism for selectively orienting the treatment probe toward the target region of, for example, a tympanic membrane. The guide structure may also support a videoscopic image capture device, illumination transmitting optical fibers, an aiming beam transmitter, and the like. Such structures facilitate myringotomy, tympanostomy tube placement, and the like, under local anesthesia in a doctor's office.

Mechanically registered videoscopic myringotomy/tympanostomy tube placement system

Apparatus and methods for nipple and breast formation are described where devices precondition or expand a target nipple tissue to reduce the pressure exerted by the skin on an eventual implant. Generally, the apparatus comprises a mold having a contact surface which is curved in conformance with a breast upon which the mold is positionable, the contact surface having an adhesive for securement upon the breast, and the mold defining a cavity along the contact surface which conforms to a size of a nipple to be formed upon the breast and where the cavity further comprises the adhesive for securement to the nipple. A breast enlargement device comprises a cup larger than the target breast and further defines an inner surface which adheres to the breast when contacted.

Apparatus and methods for nipple and breast formation

Upon filling multiple inflatable chambers of a gastric balloon structure in a patient's stomach, the gastric balloon structure assumes a natural three-dimensional kidney shape of the gastric cavity. A flexible central spine may span a gap between two inflatable chambers and may include lumens for inflation of one or both chambers. The plurality of compartments, when in an inflated state, may form a cavity therebetween through which food may pass and may leave in a stomach a residual volume of 10 ml to 100 ml.

Devices and methods for tissue transfer are described where a cannula may be inserted into the breast of a subject at one of several points of entry. Insertion of the cannula into the breast may be accomplished by using a guidance system to distinguish between tissue types. Once desirably positioned, the cannula may be withdrawn from the breast while automatically (or manually) injecting the fat in multiple deposits of adipose tissue or fat such that the deposited fat remains within the tract formed by the withdrawn cannula. Multiple tracts of the deposited fat may be injected within the breast until the breast has been desirably remodeled and/or augmented.

Tissue transfer systems

Growing community of inventors

Menlo Park, CA, United States of America

Christopher Scott Jones